Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-DLL3 antibody drug conjugates for treating cancer

Anti-DLL3 antibody drug conjugates for treating cancer

US Patent 10137204 · Granted Nov 27, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered γδ T-cells2025
Methods for selective expansion of gamma delta t-cell populations and compositio2025
Dosage unit form(s) comprising BTS and BTS(OMe) for use in boron neutron capture2025
Methods for selective expansion of delta-3 gamma delta T-cell populations and co2025
Methods for selective expansion of delta-3 gamma delta T-cell populations and co2025
Borylated amino acid compositions for use in boron neutron capture therapy and m2024
Container capable of being quickly opened2024
Hydrophobic polymers as oil rheology modifiers for agrochemical formulations2024
Verification method of osteotomy guide tool, verification system and detection e2024
Osteotomy calibration method, calibration device and orthopedic surgery system2024
Borylated amino acid compositions comprising BTS and BTS(OMe) for use in boron n2024
Portable dumbbell2024